John Sotos – Genetic Diseases


John Sotos – Genetic Diseases



Dr. John Sotos, a cardiologist and worldwide medical director at Intel, thinks mobile health is the key to defeating what he calls “the worst disease in the world”.

“The worst disease in the world is hypertension,” he said at the HIMSS Connected Health Conference. “And that may seem surprising but it’s quantifiably true. It’s responsible for over half of the fatal strokes in the world, over half of the fatal heart attacks in the world, all the hypertensive heart disease in the world, and over half of the chronic kidney failure in the world. As a result, it’s responsible for one in eight deaths in the entire world.”

operating system (and set of application programs) built on the digital molecules DNA and RNA.

The genome has thousands of publicly documented, unpatchable security vulnerabilities, previously called “genetic diseases.” Because emerging DNA/RNA technologies, including CRISPR-Cas9 and especially those arising from the Cancer Moonshot program, will create straightforward methods to digitally reprogram the genome in free-living humans, malicious exploitation of genomic vulnerabilities will soon be possible on a wide scale.

This presentation shows the breathtaking potential for such hacks, most notably the exquisite targeting precision that the genome supports — in effect, population, and time — spanning annoyance to organized crime to civilization-ending pandemics far worse than Ebola.

Because humans are poor at responding to less-than-immediate threats, and because there is no marketplace demand for defensive technologies on the DNA/RNA platform, the hacker community has an important role to play in devising thought-experiments to convince policy makers to initiate defensive works, before offensive hacks can be deployed in the wild. Hackers can literally save the world… from ourselves.


Intel is evil pure evil
educate yourself



2,789 total views, 2 views today

Sorry, comments are closed for this post.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Cookie policy, uses certain technologies on its network of websites, software applications, or any other products offered by to collect information that helps us improve your online experience. In this Cookie Policy, we refer to these technologies, which include cookies, pixels, web beacons, and gifs, collectively as “cookies.” This policy explains the different types of cookies used on the Services and how you can control them. We may change this Cookie Policy at any time: please take a look at the “last modified” legend at the top of this page to see when this Cookie Policy was last revised. Any changes in this Cookie Policy will become effective when we make the revised Cookie Policy available on or through By agreeing to this Cookie Policy, or by using the Services or any service of ours that links to this Cookie Policy, you expressly consent to information handling practices and storage and access of cookies as described in this policy. We hope that this policy helps you understand, and feel more confident about, our use of cookies. If you have any further queries, please contact us This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.